The invention is directed to compounds of Formula I:
wherein Q, Y, A are set forth in the specification, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof, that inhibit protein kinases, especially Aurora-1, Aurora-2 and Aurora-3 kinases.
本发明涉及I式化合物,其中Q、Y、A如规范中所述,以及其溶剂化物、
水合物、互变异构体或药学上可接受的盐,其能抑制蛋白激酶,尤其是Aurora-1、Aurora-2和Aurora-3激酶。